Placental epigenetic clocks and maternal-fetal endocrine crosstalk: From DNA Methylation to Gestational Age Prediction and Preterm Birth Risk

Preterm birth remains the leading cause of neonatal mortality and lifelong morbidity worldwide, yet its underlying biology has long eluded precise molecular definition. The discovery of placental epigenetic clocks is highly accurate. Gestationally programmed DNA methylation signatures has dramatically reframed gestational age as a measurable biological variable rather than a mere calendar milestone. This review synthesizes a transformative body of evidence demonstrating that accelerated placental epigenetic aging, driven by dysregulation of the maternal-fetal glucocorticoid, thyroid, and sex-steroid axes constitutes one of the earliest and most powerful predictors of both spontaneous and medically indicated preterm delivery yet identified. Through integration of large prospective cohorts, single-cell atlases, organoid models, and cell-free DNA technologies, we reveal how endocrine perturbations induce premature trophoblast senescence, inflammatory priming, and telomere-independent clock acceleration, converging on a final common pathway to parturition. Critically, existing endocrine-modifying interventions, vaginal progesterone, low-dose aspirin, and levothyroxine can decelerate these clocks when initiated in high-risk pregnancies identified by non-invasive blood-based assays that now outperform all conventional screening tools. As randomized trials of clock-guided precision prevention launch globally, placental epigenetic age assessment stands poised to shift obstetrics from reactive management to proactive, biologically informed care, offering the first realistic prospect of substantially reducing the global burden of prematurity and its intergenerational consequences.